Position in LGVN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$143,243
-$68,519 QoQ
Shares Held
203,761
+0.1% QoQ
Ownership
0.639%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 39 holders
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LGVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. LGVN ranks #422 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in LGVN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $143,243 | 203,761 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $211,762 | 203,618 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $71,598 | 141,501 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $106,125 | 141,501 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $183,950 | 141,501 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $218,132 | 140,731 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $231,136 | 133,605 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $250,156 | 128,947 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $49,900 | 30,994 | Shares | Defined | 2024-08-09 | |
| 2023-12-31 | $122,723 | 90,238 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $171,917 | 73,469 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $224,404 | 66,392 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $99,270 | 37,180 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $119,719 | 37,180 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $132,156 | 35,718 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $211,807 | 35,718 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $468,303 | 33,935 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $329,378 | 27,289 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $76,000 | 21,530 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $120,226 | 14,788 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||